190 related articles for article (PubMed ID: 27384186)
1. Lactoferrin Adsorbed onto Biomimetic Hydroxyapatite Nanocrystals Controlling - In Vivo - the Helicobacter pylori Infection.
Fulgione A; Nocerino N; Iannaccone M; Roperto S; Capuano F; Roveri N; Lelli M; Crasto A; Calogero A; Pilloni AP; Capparelli R
PLoS One; 2016; 11(7):e0158646. PubMed ID: 27384186
[TBL] [Abstract][Full Text] [Related]
2. Biological activity of lactoferrin-functionalized biomimetic hydroxyapatite nanocrystals.
Nocerino N; Fulgione A; Iannaccone M; Tomasetta L; Ianniello F; Martora F; Lelli M; Roveri N; Capuano F; Capparelli R
Int J Nanomedicine; 2014; 9():1175-84. PubMed ID: 24623976
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human lactoferrin enhances the efficacy of triple therapy in mice infected with Helicobacter pylori.
Yuan Y; Wu Q; Cheng G; Liu X; Liu S; Luo J; Zhang A; Bian L; Chen J; Lv J; Dong X; Yang G; Zhu Y; Ma L
Int J Mol Med; 2015 Aug; 36(2):363-8. PubMed ID: 26080893
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of Helicobacter pylori infection by bovine milk glycoconjugates in a BAlb/cA mouse model.
Wang X; Hirmo S; Willén R; Wadström T
J Med Microbiol; 2001 May; 50(5):430-435. PubMed ID: 11339250
[TBL] [Abstract][Full Text] [Related]
5. Adsorption and spectroscopic characterization of lactoferrin on hydroxyapatite nanocrystals.
Iafisco M; Di Foggia M; Bonora S; Prat M; Roveri N
Dalton Trans; 2011 Jan; 40(4):820-7. PubMed ID: 21152600
[TBL] [Abstract][Full Text] [Related]
6. Changes in gastric microbiota induced by Helicobacter pylori infection and preventive effects of Lactobacillus plantarum ZDY 2013 against such infection.
Pan M; Wan C; Xie Q; Huang R; Tao X; Shah NP; Wei H
J Dairy Sci; 2016 Feb; 99(2):970-981. PubMed ID: 26709179
[TBL] [Abstract][Full Text] [Related]
7. Biomimetic hydroxyapatite nanocrystals are an active carrier for
Fulgione A; Ianniello F; Papaianni M; Contaldi F; Sgamma T; Giannini C; Pastore S; Velotta R; Della Ventura B; Roveri N; Lelli M; Capuano F; Capparelli R
Int J Nanomedicine; 2019; 14():2219-2232. PubMed ID: 30992664
[TBL] [Abstract][Full Text] [Related]
8. Lactoferrin and desferrioxamine are ineffective in the treatment of Helicobacter pylori infection and may enhance H. pylori growth and gastric inflammation in mice.
Huynh HQ; Campbell MA; Couper RT; Tran CD; Lawrence A; Butler RN
Lett Appl Microbiol; 2009 May; 48(5):517-22. PubMed ID: 19187488
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic Activities of
Do AD; Su CH; Hsu YM
Front Immunol; 2021; 12():796177. PubMed ID: 35095872
[No Abstract] [Full Text] [Related]
10.
Kang S; Guo Y; Rao J; Jin H; You HJ; Ji GE
Food Funct; 2021 Nov; 12(21):11024-11032. PubMed ID: 34657941
[No Abstract] [Full Text] [Related]
11. Antibiotic properties of bovine lactoferrin on Helicobacter pylori.
Dial EJ; Hall LR; Serna H; Romero JJ; Fox JG; Lichtenberger LM
Dig Dis Sci; 1998 Dec; 43(12):2750-6. PubMed ID: 9881510
[TBL] [Abstract][Full Text] [Related]
12. [Preparation of
Nie J; Wu Y; Han X; Li Y; Wang H; Zhang H
Nan Fang Yi Ke Da Xue Xue Bao; 2024 May; 44(5):867-875. PubMed ID: 38862444
[TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory properties of gastric-derived Lactobacillus plantarum XB7 in the context of Helicobacter pylori infection.
Thiraworawong T; Spinler JK; Werawatganon D; Klaikeaw N; Venable SF; Versalovic J; Tumwasorn S
Helicobacter; 2014 Apr; 19(2):144-55. PubMed ID: 24387083
[TBL] [Abstract][Full Text] [Related]
14. Lactobacillus fermentum UCO-979C strongly inhibited Helicobacter pylori SS1 in Meriones unguiculatus.
Merino JS; García A; Pastene E; Salas A; Saez K; González CL
Benef Microbes; 2018 Jun; 9(4):625-627. PubMed ID: 29633633
[TBL] [Abstract][Full Text] [Related]
15. Characterization of Lactobacillus salivarius strains B37 and B60 capable of inhibiting IL-8 production in Helicobacter pylori-stimulated gastric epithelial cells.
Panpetch W; Spinler JK; Versalovic J; Tumwasorn S
BMC Microbiol; 2016 Oct; 16(1):242. PubMed ID: 27756217
[TBL] [Abstract][Full Text] [Related]
16. Lactobacillus paracasei strain 06TCa19 suppresses inflammatory chemokine induced by Helicobacter pylori in human gastric epithelial cells.
Takeda S; Igoshi K; Tsend-Ayush C; Oyunsuren T; Sakata R; Koga Y; Arima Y; Takeshita M
Hum Cell; 2017 Oct; 30(4):258-266. PubMed ID: 28434172
[TBL] [Abstract][Full Text] [Related]
17. Bovine lactoferrin enhances the efficacy of levofloxacin-based triple therapy as first-line treatment of Helicobacter pylori infection: an in vitro and in vivo study.
Ciccaglione AF; Di Giulio M; Di Lodovico S; Di Campli E; Cellini L; Marzio L
J Antimicrob Chemother; 2019 Apr; 74(4):1069-1077. PubMed ID: 30668729
[TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of anti-Helicobacter pylori urease immunoglobulin Y from egg yolk of immunized hens and Lactobacillus johnsonii No.1088 to inhibit the growth of Helicobacter pylori in vitro and in vivo.
Aiba Y; Umeda K; Rahman S; Nguyen SV; Komatsu Y
Vaccine; 2019 May; 37(23):3106-3112. PubMed ID: 31031029
[TBL] [Abstract][Full Text] [Related]
19. Probiotic BIFICO cocktail ameliorates Helicobacter pylori induced gastritis.
Yu HJ; Liu W; Chang Z; Shen H; He LJ; Wang SS; Liu L; Jiang YY; Xu GT; An MM; Zhang JD
World J Gastroenterol; 2015 Jun; 21(21):6561-71. PubMed ID: 26074694
[TBL] [Abstract][Full Text] [Related]
20. Reduction of overall Helicobacter pylori colonization levels in the stomach of Mongolian gerbil by Lactobacillus johnsonii La1 (LC1) and its in vitro activities against H. pylori motility and adherence.
Isobe H; Nishiyama A; Takano T; Higuchi W; Nakagawa S; Taneike I; Fukushima Y; Yamamoto T
Biosci Biotechnol Biochem; 2012; 76(4):850-2. PubMed ID: 22484956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
